Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Gross Margin (2016 - 2025)

Historic Gross Margin for STRATA Skin Sciences (SSKN) over the last 13 years, with Q3 2025 value amounting to 60.38%.

  • STRATA Skin Sciences' Gross Margin rose 3000.0% to 60.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.32%, marking a year-over-year increase of 18000.0%. This contributed to the annual value of 56.85% for FY2024, which is 15100.0% up from last year.
  • Latest data reveals that STRATA Skin Sciences reported Gross Margin of 60.38% as of Q3 2025, which was up 3000.0% from 56.19% recorded in Q2 2025.
  • Over the past 5 years, STRATA Skin Sciences' Gross Margin peaked at 69.72% during Q3 2021, and registered a low of 45.6% during Q1 2024.
  • Moreover, its 5-year median value for Gross Margin was 58.71% (2024), whereas its average is 58.89%.
  • Its Gross Margin has fluctuated over the past 5 years, first soared by 157600bps in 2021, then plummeted by -123900bps in 2024.
  • Over the past 5 years, STRATA Skin Sciences' Gross Margin (Quarter) stood at 66.25% in 2021, then dropped by -2bps to 64.59% in 2022, then dropped by -14bps to 55.25% in 2023, then increased by 6bps to 58.71% in 2024, then grew by 3bps to 60.38% in 2025.
  • Its Gross Margin stands at 60.38% for Q3 2025, versus 56.19% for Q2 2025 and 53.54% for Q1 2025.